Nuvation Bio rises as B. Riley starts at Buy on launch trajectory for lead drug
Nuvation Bio rises as B. Riley starts at Buy on launch trajectory for lead drug
Nuvation Bio rises as B. Riley starts at Buy on launch trajectory for lead drug
Fairfax Financial: A Generational Compounder In The Middle Of A Re-Rating
Fermi: With Great Potential Comes Great Risk
Microsoft's Pullback Presents An Appealing Buying Opportunity For Investors (Rating Upgrade)
The 2025 NFL season hasn’t gone as planned for the Las Vegas Raiders, and with a 2-7 record, questions about the coaching staff are emerging as the front office starts…
FedEx and UPS Ground MD-11 Fleets After Fatal Louisville Crash Kills 14
FLKR: Solid Hold Following 2025 Rally
Aspen Aerogels: No Insulation For Investors
e.l.f. Beauty: Time To Get Greedy After The Selloff (Rating Upgrade)
PTC Therapeutics: Sephience Starts Well, But Translarna Is The Swing Factor